Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An update from BONESUPPORT HOLDING AB ( (SE:BONEX) ) is now available.
BONESUPPORT HOLDING AB reported strong financial growth in Q3 2025, with a 24% increase in net sales and a 92.9% gross margin. The US segment showed significant growth, supported by new Medicare reimbursement approvals and positive clinical study results, enhancing the company’s market positioning and operational impact.
The most recent analyst rating on (SE:BONEX) stock is a Hold with a SEK297.00 price target. To see the full list of analyst forecasts on BONESUPPORT HOLDING AB stock, see the SE:BONEX Stock Forecast page.
More about BONESUPPORT HOLDING AB
BONESUPPORT HOLDING AB operates in the medical technology industry, focusing on innovative injectable bioceramic bone graft substitutes. Their primary products, such as CERAMENT G and CERAMENT V, are designed to treat bone infections and aid in bone healing, with a strong market presence in the US and Europe.
Average Trading Volume: 149,307
Technical Sentiment Signal: Sell
Current Market Cap: SEK17.11B
For detailed information about BONEX stock, go to TipRanks’ Stock Analysis page.